Making the type 2 inflammation connection between upper and lower respiratory diseases
Type 2 inflammation, which contributes to most moderate-to-severe asthma cases, can also be involved in upper respiratory tract diseases like chronic rhinosinusitis with nasal polyposis. These diseases are often treated with immunosuppressants that don't specifically address their root causes and can be challenging to use long term. Learn about Sanofi and Regeneron's work in type 2 inflammation and the latest research in respiratory diseases at the American Thoracic Society (ATS) Annual Meeting (May 13-18).
New monkeypox cases raise specter of wider outbreak; 'pharma bro' Martin Shkreli released from prison
Reviewed by Knowledge World
on
May 18, 2022
Rating: 5
No comments